Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fenghua Jieyin is a Traditional Chinese Medicine (TCM) topical formulation, primarily available as a lotion or wash, developed and manufactured by Jiangxi Fenghua Pharmaceutical. It is specifically indicated for the treatment of gynecological infections, including vulvovaginal candidiasis (VVC) and trichomonas vaginitis. The formulation is composed of a synergistic blend of herbal extracts, such as *Sophora flavescens*, *Phellodendron amurense*, *Cnidium monnieri*, *Kochia scoparia*, *Artemisia argyi*, and *Smilax glabra*. These botanical ingredients contain bioactive compounds like matrine, berberine, and osthole, which possess broad-spectrum antifungal, antibacterial, and antiparasitic properties. The drug works by disrupting microbial cell membranes and inhibiting the production of pro-inflammatory mediators, thereby alleviating symptoms such as pruritus, abnormal leucorrhea, and local inflammation associated with vaginal dysbiosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fenghua Jieyin.